IBDEI1OF ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28051,1,4,0)
 ;;=4^K75.89
 ;;^UTILITY(U,$J,358.3,28051,2)
 ;;=^5008829
 ;;^UTILITY(U,$J,358.3,28052,0)
 ;;=K76.4^^132^1323^21
 ;;^UTILITY(U,$J,358.3,28052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28052,1,3,0)
 ;;=3^Peliosis Hepatis
 ;;^UTILITY(U,$J,358.3,28052,1,4,0)
 ;;=4^K76.4
 ;;^UTILITY(U,$J,358.3,28052,2)
 ;;=^91041
 ;;^UTILITY(U,$J,358.3,28053,0)
 ;;=K71.50^^132^1323^25
 ;;^UTILITY(U,$J,358.3,28053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28053,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/o Ascites
 ;;^UTILITY(U,$J,358.3,28053,1,4,0)
 ;;=4^K71.50
 ;;^UTILITY(U,$J,358.3,28053,2)
 ;;=^5008799
 ;;^UTILITY(U,$J,358.3,28054,0)
 ;;=K71.51^^132^1323^26
 ;;^UTILITY(U,$J,358.3,28054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28054,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/ Ascites
 ;;^UTILITY(U,$J,358.3,28054,1,4,0)
 ;;=4^K71.51
 ;;^UTILITY(U,$J,358.3,28054,2)
 ;;=^5008800
 ;;^UTILITY(U,$J,358.3,28055,0)
 ;;=K71.7^^132^1323^29
 ;;^UTILITY(U,$J,358.3,28055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28055,1,3,0)
 ;;=3^Toxic Liver Disease w/ Fibrosis & Cirrhosis of Liver
 ;;^UTILITY(U,$J,358.3,28055,1,4,0)
 ;;=4^K71.7
 ;;^UTILITY(U,$J,358.3,28055,2)
 ;;=^5008802
 ;;^UTILITY(U,$J,358.3,28056,0)
 ;;=K71.8^^132^1323^33
 ;;^UTILITY(U,$J,358.3,28056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28056,1,3,0)
 ;;=3^Toxic Liver Disease w/ Oth Disorders of Liver
 ;;^UTILITY(U,$J,358.3,28056,1,4,0)
 ;;=4^K71.8
 ;;^UTILITY(U,$J,358.3,28056,2)
 ;;=^5008803
 ;;^UTILITY(U,$J,358.3,28057,0)
 ;;=K71.9^^132^1323^34
 ;;^UTILITY(U,$J,358.3,28057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28057,1,3,0)
 ;;=3^Toxic Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,28057,1,4,0)
 ;;=4^K71.9
 ;;^UTILITY(U,$J,358.3,28057,2)
 ;;=^5008804
 ;;^UTILITY(U,$J,358.3,28058,0)
 ;;=K75.2^^132^1323^20
 ;;^UTILITY(U,$J,358.3,28058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28058,1,3,0)
 ;;=3^Nonspecific Reactive Hepatitis
 ;;^UTILITY(U,$J,358.3,28058,1,4,0)
 ;;=4^K75.2
 ;;^UTILITY(U,$J,358.3,28058,2)
 ;;=^5008826
 ;;^UTILITY(U,$J,358.3,28059,0)
 ;;=K75.3^^132^1323^13
 ;;^UTILITY(U,$J,358.3,28059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28059,1,3,0)
 ;;=3^Granulomatous Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,28059,1,4,0)
 ;;=4^K75.3
 ;;^UTILITY(U,$J,358.3,28059,2)
 ;;=^5008827
 ;;^UTILITY(U,$J,358.3,28060,0)
 ;;=K76.6^^132^1323^22
 ;;^UTILITY(U,$J,358.3,28060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28060,1,3,0)
 ;;=3^Portal Hypertension
 ;;^UTILITY(U,$J,358.3,28060,1,4,0)
 ;;=4^K76.6
 ;;^UTILITY(U,$J,358.3,28060,2)
 ;;=^5008834
 ;;^UTILITY(U,$J,358.3,28061,0)
 ;;=F20.3^^132^1324^25
 ;;^UTILITY(U,$J,358.3,28061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28061,1,3,0)
 ;;=3^Undifferentiated/Atypical Schizophrenia
 ;;^UTILITY(U,$J,358.3,28061,1,4,0)
 ;;=4^F20.3
 ;;^UTILITY(U,$J,358.3,28061,2)
 ;;=^5003472
 ;;^UTILITY(U,$J,358.3,28062,0)
 ;;=F20.9^^132^1324^21
 ;;^UTILITY(U,$J,358.3,28062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28062,1,3,0)
 ;;=3^Schizophrenia,Unspec
 ;;^UTILITY(U,$J,358.3,28062,1,4,0)
 ;;=4^F20.9
 ;;^UTILITY(U,$J,358.3,28062,2)
 ;;=^5003476
 ;;^UTILITY(U,$J,358.3,28063,0)
 ;;=F31.9^^132^1324^6
 ;;^UTILITY(U,$J,358.3,28063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28063,1,3,0)
 ;;=3^Bipolar Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,28063,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,28063,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,28064,0)
 ;;=F31.72^^132^1324^7
 ;;^UTILITY(U,$J,358.3,28064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28064,1,3,0)
 ;;=3^Bipolr Disorder,Full Remis,Most Recent Episode Hypomanic
